Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Research Report 2024
Pharmaceutical Contract Sales Outsourcing (CSO), also known as Contract Sales Organization (CSO),means an Entity commonly and primarily known as a "contract sales organization" that is engaged primarily in the business of promoting products for third parties and is not, and is not a direct or indirect affiliate of, an entity commonly and primarily known as a "pharmaceutical", "biopharmaceutical" or "biotechnology" company; and (2) "Contract Sales Arrangement" shall mean an arrangement (that is terminable by the Company within three years without payment or penalty) between the Company and a Contract Sales Organization under which such Contract Sales Organization (A) would promote (and would only be granted such rights as are necessary to promote) a Company Pharmaceutical Product for a fee (which may be fixed or based upon a percentage of revenues or otherwise) but (B) would not be granted any research, development, manufacturing, sublicensing or other rights with respect to such Company Pharmaceutical Product or with respect to any Intellectual Property underlying or related to such Company Pharmaceutical Product except as necessary for the purpose of clause "(A)".
The Pharmaceutical Contract Sales Outsourcing (CSO) market covers Personal Promotion, Non-personal Promotion, Others, etc. The typical players include IQVIA, PHOENIX Group, Amplity Health, Ashfield Engage (Inizio), Syneos Health, EVERSANA, CMIC Group, EPS Corporation, etc.
According to MRAResearch’s new survey, global Pharmaceutical Contract Sales Outsourcing (CSO) market is projected to reach US$ 12310 million in 2033, increasing from US$ 7661.2 million in 2022, with the CAGR of 7.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Contract Sales Outsourcing (CSO) market research.
Global key players of pharmaceutical contract sales outsourcing include China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, etc. The top five players hold a share over 40%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Pharmaceutical Contract Sales Outsourcing (CSO) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
China Medical System (CMS)
IQVIA
PHOENIX Group
EVERSANA
Ashfield Engage (Inizio)
Amplity Health
Sinco Pharma
Syneos Health
EPS Corporation
Uniphar Group
CMIC Group
SciClone Pharmaceuticals
China Pioneer Pharma
Promoveo Health
CSO Pharmitalia
GTS Solution
QFR Solutions
Segment by Type
Personal Promotion
Non-personal Promotion
Others
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pharmaceutical Contract Sales Outsourcing (CSO) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source![](http://localhost/mraccuracy/images/About Report.webp)
The Pharmaceutical Contract Sales Outsourcing (CSO) market covers Personal Promotion, Non-personal Promotion, Others, etc. The typical players include IQVIA, PHOENIX Group, Amplity Health, Ashfield Engage (Inizio), Syneos Health, EVERSANA, CMIC Group, EPS Corporation, etc.
According to MRAResearch’s new survey, global Pharmaceutical Contract Sales Outsourcing (CSO) market is projected to reach US$ 12310 million in 2033, increasing from US$ 7661.2 million in 2022, with the CAGR of 7.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Contract Sales Outsourcing (CSO) market research.
Global key players of pharmaceutical contract sales outsourcing include China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, etc. The top five players hold a share over 40%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Pharmaceutical Contract Sales Outsourcing (CSO) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
China Medical System (CMS)
IQVIA
PHOENIX Group
EVERSANA
Ashfield Engage (Inizio)
Amplity Health
Sinco Pharma
Syneos Health
EPS Corporation
Uniphar Group
CMIC Group
SciClone Pharmaceuticals
China Pioneer Pharma
Promoveo Health
CSO Pharmitalia
GTS Solution
QFR Solutions
Segment by Type
Personal Promotion
Non-personal Promotion
Others
Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pharmaceutical Contract Sales Outsourcing (CSO) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
![](http://localhost/mraccuracy/images/About Report.webp)